1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ESSA PHARMA INC

Essa Pharma Inc

XNAS: EPIX

Download real time

1.60 0.00 (0.00%)

83.33% Fall from 52W High

22,566 XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
6S
12W
0O
2T
71

Market Cap

Below industry Median
-2.3

PE TTM

Negative PE TTM
0.1

PEG TTM

PEG TTM is less than 1
0.6

Price to Book

Below industry Median
0.0

Beta 1Year

Very Low volatility


Insider Trading disclosures for Essa Pharma Inc

The latest disclosure was made by Peter Virsik in Essa Pharma Inc where a trade of 694 Common Shares done at an average price of $6.0 was reported to US exchanges on Oct. 7, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.03 per share. 07 Oct 2024 694 7,776 (0%) 0% 6.0 4,185 Common Shares
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.00 per share. 09 Sep 2024 694 8,470 (0%) 0% 6 4,164 Common Shares
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.03 per share. 03 Sep 2024 2,082 9,164 (0%) 0% 6.0 12,554 Common Shares
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.95 per share. 06 May 2024 694 11,246 (0%) 0% 6.9 4,823 Common Shares
Richard M. Glickman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.90 per share. 24 Apr 2024 3,750 43,240 (0%) 0% 4.9 18,375 Common Shares
Richard M. Glickman Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Apr 2024 3,750 0 - - Options
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 7.94 per share. 05 Apr 2024 694 11,940 (0%) 0% 7.9 5,510 Common Shares
David Wood Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 110,000 110,000 - - Options
Franklin M. Berger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
David Ross Parkinson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 350,000 350,000 - - Options
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 70,000 70,000 - - Options
John Alexander Martin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
Marella Thorell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
Sanford S. Zweifach Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
Gary Sollis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
Scott Requadt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
Peter Virsik Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 110,000 110,000 - - Options
Alessandra Cesano Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 200,000 200,000 - - Options
Lauren Merendino Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 25,000 25,000 - - Options
Philip Kantoff Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2024 50,000 50,000 - - Options
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 8.98 per share. 05 Mar 2024 694 12,634 (0%) 0% 9.0 6,232 Common Shares
Peter Virsik Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. 06 Feb 2024 72,782 86,110 (1%) 1% 3.2 235,086 Common Shares
Virsik Peter Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.29 per share. 06 Feb 2024 72,782 13,328 (0%) 1% 10.3 748,927 Common Shares
Peter Virsik Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Feb 2024 72,782 895,000 - - Options
Virsik Peter Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. 05 Feb 2024 500 13,828 (0%) 0% 3.2 1,615 Common Shares
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 9.25 per share. 05 Feb 2024 694 13,328 (0%) 0% 9.3 6,420 Common Shares
Virsik Peter Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Feb 2024 500 967,782 - - Options
Virsik Peter Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.04 per share. 05 Feb 2024 500 13,328 (0%) 0% 10.0 5,020 Common Shares
Virsik Peter Chief Operating Officer Sale of securities on an exchange or to another person at price $ 10.01 per share. 16 Jan 2024 1,718 14,022 (0%) 0% 10.0 17,197 Common Shares
Virsik Peter Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2024 1,718 968,282 - - Options
Peter Virsik Chief Operating Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.23 per share. 16 Jan 2024 1,718 15,740 (0%) 0% 3.2 5,549 Common Shares
Peter Virsik Chief Operating Officer Sale of securities on an exchange or to another person at price $ 6.11 per share. 05 Jan 2024 699 14,022 (0%) 0% 6.1 4,271 Common Shares
Ross Parkinson David Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.30 per share. 14 Dec 2023 9,223 65,675 (1%) 0% 2.3 21,213 Common Shares
Requadt Scott Director Other type of transaction at price $ 0.00 per share. 30 Oct 2023 17,502 42,502 (0%) 0% 0 Common Shares
Scott Requadt Director Other type of transaction at price $ 0.00 per share. 30 Oct 2023 12,500 30,002 (0%) 0% 0 Common Shares
David Wood Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.60 per share. 30 Dec 2022 8,302 33,343 (0%) 0% 2.6 21,585 Common Shares
David Ross Parkinson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.60 per share. 22 Dec 2022 3,067 56,542 (0%) 0% 2.6 7,974 Common Shares
David Ross Parkinson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.39 per share. 22 Dec 2022 21,367 53,475 (0%) 0% 2.4 51,067 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 2.53 per share. 14 Dec 2022 43,617 756,627 (13%) 0% 2.5 110,351 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 2.67 per share. 14 Dec 2022 50,000 800,244 (13%) 0% 2.7 133,500 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 2.86 per share. 14 Dec 2022 50,000 850,244 (14%) 0% 2.9 143,000 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 2.90 per share. 14 Dec 2022 32,000 900,244 (15%) 0% 2.9 92,800 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 3.00 per share. 14 Dec 2022 25,000 932,244 (16%) 0% 3 75,000 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 2.42 per share. 14 Dec 2022 34,334 684,404 (11%) 0% 2.4 83,088 Common Shares
Franklin M. Berger Director Sale of securities on an exchange or to another person at price $ 2.41 per share. 14 Dec 2022 37,889 718,738 (12%) 0% 2.4 91,312 Common Shares
David Ross Parkinson Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.96 per share. 30 Jun 2022 4,887 32,108 (0%) 0% 3.0 14,456 Common Shares
Peter Virsik Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Franklin M. Berger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 22,500 22,500 - - Stock Option (Right to Buy)
David Ross Parkinson Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 222,500 222,500 - - Stock Option (Right to Buy)
Richard M. Glickman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 35,000 35,000 - - Stock Option (Right to Buy)
John Alexander Martin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 22,500 22,500 - - Stock Option (Right to Buy)
Marella Thorell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 22,500 22,500 - - Stock Option (Right to Buy)
Sanford S. Zweifach Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 22,500 22,500 - - Stock Option (Right to Buy)
David Wood Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Gary Sollis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 22,500 22,500 - - Stock Option (Right to Buy)
Scott Requadt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 22,500 22,500 - - Stock Option (Right to Buy)
Alessandra Cesano Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jun 2022 90,000 90,000 - - Stock Option (Right to Buy)
Franklin M. Berger Director Purchase of securities on an exchange or from another person at price $ 27.00 per share. 22 Feb 2021 57,000 957,244 (16%) 0% 27 1,539,000 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters